18S ribosomal RNA
|
Rn18s
|
CCCGAAGCGTTTACTTTGAA
|
CCCTCTTAATCATGGCCTCA
|
136
|
Glyceraldehyde-3-phosphate dehydrogenase
|
Gapdh
|
GAAGGGCTCATGACCACAGT
|
GGATGCAGGGATGATGTTCT
|
117
|
Actin, beta
|
Actb
|
CACACTGTGCCCATCTATGA
|
CCGATCGTGATGACCTGACC
|
272
|
Calcium/calmodulin-dependent protein kinase II alpha
|
Camk2a
|
GCCTGGACTTTCATCGATTC
|
GGTACTGAGTGATGCGGATGT
|
141
|
Glycogen synthase kinase 3 beta
|
Gsk3β
|
GCGAGACACACCTGCCCTCTTC
|
GTGGCCAGAGGTGGGTTACTTGAC
|
66
|
Mammalian target of rapamycin (serine/threonine kinase)
|
mTOR
|
TTGGATGTTCCAACCCAAGT
|
CAGGCCTTGGTTACCAGAAA
|
106
|
Neurotrophic tyrosine kinase, receptor, type 2
|
Ntrk2
|
TGGAGGGCGACCCACTCATCA
|
TCAGCTCGG TGGGCGGGTTA
|
123
|
Neurotrophic tyrosine kinase, receptor, type 3
|
Ntrk3
|
CATCCGCTGGATGCCACCTGAAA
|
AAGACACGGCCTTGGGTGATGCA
|
50
|
Phosphoinositide-3-kinase, catalytic, beta polypeptide
|
Pik3cb
|
CCTGCGACAGATGAGTGATG
|
CAATCCTCCGGTTGTCAAGT
|
134
|
V-raf murine sarcoma viral oncogene homolog B1
|
Braf
|
CATGGCGACGTGGCAGTGAAAATG
|
TGAGGTGTGGGTGCTGTCACATTC
|
50
|
Glyceraldehyde-3-phosphate dehydrogenase-3-prime
|
Gapdh-3′
|
GGCTGGCATTGCTCTCAA
|
GAGGTCCACCACCCTGTTG
|
88
|
Glyceraldehyde-3-phosphate dehydrogenase-5-prime
|
Gapdh-5′
|
GACAGCCGCATCTTCTTG
|
CACCGACCTTCACCATCTTG
|
63
|
Actin, beta-3-prime
|
Actb-3′
|
CCTAGCACCATGAAGATCAAGA
|
GCCAGGATAGAGCCACCAATC
|
77
|
Actin, beta-5-prime |
Actb-5′
|
ACCCAGATCATGTTTGAGACCTT |
CAGAGGCATACAGGGACAAC |
79 |